Literature DB >> 15728481

In vivo and in absence of a thymus, the enforced expression of the Notch ligands delta-1 or delta-4 promotes T cell development with specific unique effects.

Alix de La Coste1, Emmanuelle Six, Nicolas Fazilleau, Laurent Mascarell, Nicolas Legrand, Marie-Pierre Mailhé, Ana Cumano, Yacine Laâbi, Antonio A Freitas.   

Abstract

The role of Notch signaling in T cell commitment during lymphoid development is well established. However, the identity of the ligand that triggers this critical signal in vivo is still unclear. By overexpressing Delta-1 and Delta-4 ligands in the hemopoietic cells of athymic nu/nu host mice, we demonstrate that, in vivo and in the absence of a thymus, Delta-1 or Delta-4 expression is sufficient to promote T cell development from the most immature progenitor stages to complete maturation of both CD8(+) and CD4(+) alphabeta T cells. The mature T cells developing in a Delta-1- or Delta-4-enriched environment express a diverse TCR repertoire, are able to proliferate upon in vitro TCR stimulation, but show different profiles of cytokine production after in vitro anti-CD3 stimulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728481     DOI: 10.4049/jimmunol.174.5.2730

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Suppression of Th2 cell development by Notch ligands Delta1 and Delta4.

Authors:  Jie Sun; Connie J Krawczyk; Edward J Pearce
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

2.  Two deltaC splice-variants have distinct signaling abilities during somitogenesis and midline patterning.

Authors:  Andrew Mara; Joshua Schroeder; Scott A Holley
Journal:  Dev Biol       Date:  2008-03-20       Impact factor: 3.582

3.  Canonical Notch Signaling Directs the Fate of Differentiating Neurocompetent Progenitors in the Mammalian Olfactory Epithelium.

Authors:  Daniel B Herrick; Zhen Guo; Woochan Jang; Nikolai Schnittke; James E Schwob
Journal:  J Neurosci       Date:  2018-05-08       Impact factor: 6.167

4.  Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth.

Authors:  Yuhui Huang; Luping Lin; Anil Shanker; Anshu Malhotra; Li Yang; Mikhail M Dikov; David P Carbone
Journal:  Cancer Res       Date:  2011-08-08       Impact factor: 12.701

Review 5.  E proteins and the regulation of early lymphocyte development.

Authors:  Renée F de Pooter; Barbara L Kee
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

6.  Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation.

Authors:  Valerie Besseyrias; Emma Fiorini; Lothar J Strobl; Ursula Zimber-Strobl; Alexis Dumortier; Ute Koch; Marie-Laure Arcangeli; Sophie Ezine; H Robson Macdonald; Freddy Radtke
Journal:  J Exp Med       Date:  2007-01-29       Impact factor: 14.307

7.  Notch γ-secretase inhibitor dibenzazepine attenuates angiotensin II-induced abdominal aortic aneurysm in ApoE knockout mice by multiple mechanisms.

Authors:  Yue-Hong Zheng; Fang-Da Li; Cui Tian; Hua-Liang Ren; Jie Du; Hui-Hua Li
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

8.  T Cells Development Is Different between Thymus from Normal and Intrauterine Growth Restricted Pig Fetus at Different Gestational Stage.

Authors:  Yan Lin; Junjun Wang; Xiaoqiu Wang; Weizong Wu; Changhua Lai
Journal:  Asian-Australas J Anim Sci       Date:  2013-03       Impact factor: 2.509

9.  Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment.

Authors:  Leonor Remédio; Tânia Carvalho; Francisco Caiado; Ana Bastos-Carvalho; Diana Martins; António Duarte; Hideo Yagita; Sergio Dias
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment.

Authors:  Ute Koch; Emma Fiorini; Rui Benedito; Valerie Besseyrias; Karin Schuster-Gossler; Michel Pierres; Nancy R Manley; Antonio Duarte; H Robson Macdonald; Freddy Radtke
Journal:  J Exp Med       Date:  2008-09-29       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.